Boston Direct Health
- PRP Therapy
- IV Therapy
- Laser Therapy (LLLT)
- Acne Treatment
- Red Light Therapy
Boston, MA
Boston has 3 providers offering psoriasis care, ranging from conventional dermatology with biologics to integrative protocols with phototherapy and IV nutrient support. The FDA-approved biologic stack includes Humira (adalimumab), Stelara (ustekinumab), Cosentyx (secukinumab), Taltz (ixekizumab), Skyrizi (risankizumab), and Tremfya (guselkumab), with Strong evidence for moderate to severe plaque psoriasis. On the device side, the XTRAC excimer laser is FDA-cleared for psoriasis, vitiligo, and atopic dermatitis, typical course 10 to 20 sessions at 100 to 200 dollars each. Home and in-clinic narrowband UVB phototherapy is widely available in Boston. LED phototherapy and IV nutrient therapy are offered by integrative practices, though evidence is Emerging to Insufficient for psoriasis specifically. Massachusetts insurers typically cover biologics after step therapy with topical steroids, methotrexate, and sometimes phototherapy. A reputable Boston psoriasis clinic starts with a dermatology evaluation, PASI scoring, and a discussion of psoriatic arthritis screening.
Regulatory context
The "other" category is a catchall for regenerative wellness modalities with inconsistent federal oversight. Red light therapy devices (photobiomodulation) have narrow FDA 510(k) clearances for acne, muscle pain, and wound healing, not systemic regeneration. Whole-body cryotherapy is NOT FDA-approved for any medical indication and received an FDA safety communication in July 2016 warning of asphyxiation, frostbite, and burn risks. Ozone therapy is NOT FDA-approved for any medical use and the FDA has stated ozone is a toxic gas with no known useful medical application. Condition-specific regenerative offerings (hair restoration with minoxidil or finasteride, ED care beyond PDE5 inhibitors and shockwave) have varying approval depending on route and drug source.
The Massachusetts Board of Registration in Medicine has taken a strict posture on medical spa oversight and has issued public advisories about scope of practice for injectables and device-based procedures. Ozone and chelation clinics making disease-treatment claims face strong enforcement. The Attorney General's Office pursues deceptive health claims under M.G.L. Ch. 93A. Enforcement is strict, particularly in the Boston metro area where the medical spa market is large.
Explore related care